These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26001971)

  • 1. Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma.
    Créancier L; Vandenberghe I; Gomes B; Dejean C; Blanchet JC; Meilleroux J; Guimbaud R; Selves J; Kruczynski A
    Cancer Lett; 2015 Aug; 365(1):107-11. PubMed ID: 26001971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas.
    Butti MG; Bongarzone I; Ferraresi G; Mondellini P; Borrello MG; Pierotti MA
    Genomics; 1995 Jul; 28(1):15-24. PubMed ID: 7590742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
    Sartore-Bianchi A; Ardini E; Bosotti R; Amatu A; Valtorta E; Somaschini A; Raddrizzani L; Palmeri L; Banfi P; Bonazzina E; Misale S; Marrapese G; Leone A; Alzani R; Luo D; Hornby Z; Lim J; Veronese S; Vanzulli A; Bardelli A; Martignoni M; Davite C; Galvani A; Isacchi A; Siena S
    J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26563355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of the RET and NTRK1 gene rearrangements in papillary thyroid carcinoma in the Polish population.
    Brzeziańska E; Karbownik M; Migdalska-Sek M; Pastuszak-Lewandoska D; Włoch J; Lewiński A
    Mutat Res; 2006 Jul; 599(1-2):26-35. PubMed ID: 16483615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer.
    Park DY; Choi C; Shin E; Lee JH; Kwon CH; Jo HJ; Kim HR; Kim HS; Oh N; Lee JS; Park OK; Park E; Park J; Shin JY; Kim JI; Seo JS; Park HD; Park J
    Oncotarget; 2016 Feb; 7(7):8399-412. PubMed ID: 26716414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes.
    Greco A; Miranda C; Pagliardini S; Fusetti L; Bongarzone I; Pierotti MA
    Genes Chromosomes Cancer; 1997 Jun; 19(2):112-23. PubMed ID: 9172002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors.
    Agaram NP; Zhang L; Sung YS; Chen CL; Chung CT; Antonescu CR; Fletcher CD
    Am J Surg Pathol; 2016 Oct; 40(10):1407-16. PubMed ID: 27259011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
    Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
    Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition.
    Ardini E; Bosotti R; Borgia AL; De Ponti C; Somaschini A; Cammarota R; Amboldi N; Raddrizzani L; Milani A; Magnaghi P; Ballinari D; Casero D; Gasparri F; Banfi P; Avanzi N; Saccardo MB; Alzani R; Bandiera T; Felder E; Donati D; Pesenti E; Sartore-Bianchi A; Gambacorta M; Pierotti MA; Siena S; Veronese S; Galvani A; Isacchi A
    Mol Oncol; 2014 Dec; 8(8):1495-507. PubMed ID: 24962792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line.
    Lee SJ; Li GG; Kim ST; Hong ME; Jang J; Yoon N; Ahn SM; Murphy D; Christiansen J; Wei G; Hornby Z; Lee DW; Park JO; Park YS; Lim HY; Hong SN; Kim SH; Kang WK; Park K; Park WY; Kim KM; Lee J
    Oncotarget; 2015 Nov; 6(36):39028-35. PubMed ID: 26472021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic rearrangements of the NTRK1/NGF receptor.
    Pierotti MA; Greco A
    Cancer Lett; 2006 Jan; 232(1):90-8. PubMed ID: 16242838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proximity of TPR and NTRK1 rearranging loci in human thyrocytes.
    Roccato E; Bressan P; Sabatella G; Rumio C; Vizzotto L; Pierotti MA; Greco A
    Cancer Res; 2005 Apr; 65(7):2572-6. PubMed ID: 15805251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rearrangements of NTRK1 gene in papillary thyroid carcinoma.
    Greco A; Miranda C; Pierotti MA
    Mol Cell Endocrinol; 2010 May; 321(1):44-9. PubMed ID: 19883730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
    Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL
    Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
    Greco A; Mariani C; Miranda C; Lupas A; Pagliardini S; Pomati M; Pierotti MA
    Mol Cell Biol; 1995 Nov; 15(11):6118-27. PubMed ID: 7565764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.
    Vaishnavi A; Capelletti M; Le AT; Kako S; Butaney M; Ercan D; Mahale S; Davies KD; Aisner DL; Pilling AB; Berge EM; Kim J; Sasaki H; Park S; Kryukov G; Garraway LA; Hammerman PS; Haas J; Andrews SW; Lipson D; Stephens PJ; Miller VA; Varella-Garcia M; Jänne PA; Doebele RC
    Nat Med; 2013 Nov; 19(11):1469-1472. PubMed ID: 24162815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the NTRK1 genomic region involved in chromosomal rearrangements generating TRK oncogenes.
    Greco A; Mariani C; Miranda C; Pagliardini S; Pierotti MA
    Genomics; 1993 Nov; 18(2):397-400. PubMed ID: 8288244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene fusions and oncogenic mutations in MLH1 deficient and BRAFV600E wild-type colorectal cancers.
    Ukkola I; Nummela P; Kero M; Tammio H; Tuominen J; Kairisto V; Kallajoki M; Haglund C; Peltomäki P; Kytölä S; Ristimäki A
    Virchows Arch; 2022 Apr; 480(4):807-817. PubMed ID: 35237889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer.
    Farago AF; Le LP; Zheng Z; Muzikansky A; Drilon A; Patel M; Bauer TM; Liu SV; Ou SH; Jackman D; Costa DB; Multani PS; Li GG; Hornby Z; Chow-Maneval E; Luo D; Lim JE; Iafrate AJ; Shaw AT
    J Thorac Oncol; 2015 Dec; 10(12):1670-4. PubMed ID: 26565381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTRK fusion-positive colorectal cancer in Japanese population.
    Yonemaru J; Hashimoto T; Takayanagi D; Naka T; Yatabe Y; Kanemitsu Y; Shiraishi K; Sekine S
    Pathol Int; 2021 May; 71(5):355-359. PubMed ID: 33631044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.